| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press.
ARTICLE |
Improvement of the Therapeutic Index of Anticancer Drugs by the Superoxide Dismutase Mimic Mangafodipir
Affiliation of authors: Université Paris-René Descartes, Faculté de Médecine, Assistance Publique-Hopitaux de Paris, Hôpital Cochin, EA 1833, Paris, France
Correspondence to: Jérôme Alexandre, MD, Unité d'Oncologie Médicale, Service de Médecine Interne, Groupe hospitalier Cochin-Saint Vincent de Paul, 27 rue du Faubourg Saint Jacques, 75679 Paris cedex 14, France (e-mail: jerome.alexandre{at}cch.aphp.fr).
Background: Anticancer drugs act by increasing intracellular hydrogen peroxide levels. Mangafodipir, a superoxide dismutase (SOD) mimic with catalase and glutathione reductase activities, protects normal cells from apoptosis induced by H2O2. We investigated its and other oxidative stress modulators' effects on anticancer drug activity in vitro and in vivo. Methods: Cell lysis and intracellular reactive oxygen species levels were assessed in vitro in human leukocytes from healthy subjects and in murine CT26 colon cancer cells. Cells were exposed to the chemotherapeutic agents paclitaxel, oxaliplatin, or 5-fluorouracil, either in the presence or absence of mangafodipir and other oxidative stress modulators. Cell viability was evaluated by the methylthiazoletetrazolium assay. The effects of mangafodipir and other oxidative stress modulators on peripheral blood counts and on tumor growth were studied in BALB/c mice that were implanted with CT26 tumors and treated with 20 mg/kg paclitaxel. Survival of BALB/c mice infected with Staphylococcus aureus was also examined by treatment group. Statistical tests were two-sided. Results: In vitro lysis of leukocytes exposed to paclitaxel, oxaliplatin, or 5-fluorouracil in combination with mangafodipir was decreased by 46% (95% confidence interval [CI] = 44% to 48%), 30.5% (95% CI = 29% to 32%), and 15% (95% CI = 10% to 20%), compared with lysis of cells treated with anticancer agent alone. Mangafodipir also statistically significantly enhanced in vitro anticancer drug cytotoxicity toward CT26 cancer cells. In vivo, mangafodipir protected mice against paclitaxel-induced leukopenia. Moreover, the survival rate of mice infected with S. aureus and treated with paclitaxel was higher when mangafodipir was also administered (survival: 3 of 17 versus 14 of 17, P<.001). In addition, mangafodipir amplified the inhibitory effect of paclitaxel on CT26 tumor growth in mice. Conclusions: Mangafodipir decreased hematotoxicity and enhanced cytotoxicity of anticancer agents.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- Redox Modulation of Chemotherapy-Induced Tumor Cell Killing and Normal Tissue Toxicity
- James H. Doroshow
J Natl Cancer Inst 2006 98: 223-225.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  C. Ngo, C. Chereau, C. Nicco, B. Weill, C. Chapron, and F. Batteux Reactive Oxygen Species Controls Endometriosis Progression Am. J. Pathol., July 1, 2009; 175(1): 225 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nakai, S.-i. Iida, T. Takahashi, T. Tsujita, S. Okamoto, C. Takada, K. Akasaka, S. Ichikawa, H. Ishida, H. Kusaka, et al. K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells Cancer Res., May 1, 2009; 69(9): 3901 - 3909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kopetz, D. P. Lesslie, N. A. Dallas, S. I. Park, M. Johnson, N. U. Parikh, M. P. Kim, J. L. Abbruzzese, L. M. Ellis, J. Chandra, et al. Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress Cancer Res., May 1, 2009; 69(9): 3842 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Mir, J. Alexandre, A. Tran, J.-P. Durand, G. Pons, J.-M. Treluyer, and F. Goldwasser Relationship between GSTP1 Ile105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity Ann. Onc., April 1, 2009; 20(4): 736 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rombaldi, C. Cassini, M. Salvador, J. Saffi, and B. Erdtmann Occupational risk assessment of genotoxicity and oxidative stress in workers handling anti-neoplastic drugs during a working week Mutagenesis, March 1, 2009; 24(2): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Alexandre, Y. Hu, W. Lu, H. Pelicano, and P. Huang Novel Action of Paclitaxel against Cancer Cells: Bystander Effect Mediated by Reactive Oxygen Species Cancer Res., April 15, 2007; 67(8): 3512 - 3517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Doroshow Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity. J Natl Cancer Inst, February 15, 2006; 98(4): 223 - 225. [Full Text] [PDF]
|
|